BMBaylee R. Materia

Baylee R. Materia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Baylee R. Materia has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Leon Garland Coleman

    Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

    4 shared publications
  • Alexandra Barnett

    Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina

    1 shared publication
  • Ali A. Khan

    Warren Alpert Medical School of Brown University, Providence, Rhode Island

    1 shared publication
  • Angie Mordant

    University of North Carolina Chapel Hill

    1 shared publication
  • Ann M. Walker

    Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    1 shared publication
  • Benjamin G. Vincent

    Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

    1 shared publication

Latest Publications

  • Alcohol use reduces the efficacy of anti-PD1 immunotherapy by disrupting antitumor immunity

    by Kristen N. Gilley, Jason Garness, Ali Khan, Baylee R. Materia, Brandon Carpenter, Mitra Shabrang, Wolfgang Beckabir, Mark G. Woodcock, Chad V. Pecot, Benjamin G. Vincent, et al.

    Immune checkpoint inhibition (ICI) has improved outcomes for some patients with advanced malignancies, but relatively few have a complete response. Alcohol use is common and impairs adaptive immunity. Here, we explored the link between alcohol use and ICI efficacy in mouse models of lung and bladder cancers and performed a retrospective assessment of a cohort of patients with cancer receiving ICI therapy. In both mouse models, a regimen of moderate-to-heavy ethanol intake reduced ICI efficacy by ∼50% and increased tumor recurrence. In patients with lung cancer, regular alcohol use was associated with reduced survival benefit from ICI. Effects were less definitive in patients with bladder cancer, melanoma, and head and neck cancer, in whom alcohol use reporting was too limited. In mice bearing MB49 bladder tumors, ethanol intake reduced the number of tumor-infiltrated T cells favoring T helper 17 cell (T H 17 cell) over T H 1 cell phenotypes in tumor-associated CD4 + T cells. It also reduced the number of tissue-resident memory T cells, increased the proportion of T cells expressing the alternative immune checkpoint receptor TIGIT, and induced SREBP-mediated lipid signaling in tumor-associated T cells. Blocking TIGIT with antibodies or, to a lesser extent, inhibiting SREBP signaling with betulin improved the efficacy of PD1 receptor blockade. The findings suggest that regular alcohol use negatively affects ICI efficacy, which may be counteracted by cotargeting TIGIT. Future incorporation of patients’ alcohol use in cancer databases will help define its effect on the outcome of various therapies in multiple cancers.

  • Open Access

    Chronic Intermittent Ethanol Exposure Produces Physiological Tolerance and Distinct Behavioral Alterations Across Abstinence in Female Mice

    by Maya R. Eberle-Redding, Ann M. Walker, Shivani P. Vaidya, Jobe L. Ritchie, Lisa R. Taxier, Baylee R. Materia, Leon G. Coleman, Ryan P. Vetreno, Thomas L. Kash, Brianna E. George

    Chronic ethanol consumption produces long-lasting effects on the brain that contribute to persistent behavioral changes. This has been modeled in animals using the chronic intermittent ethanol (CIE) paradigm, which induces escalation of consumption and alterations in affective and cognitive behavior. While this model has been well characterized in male subjects, the effects of CIE in females and long-term effects that persist beyond the acute withdrawal remain relatively underexplored. Here, female C57BL/6J mice were exposed to four weeks of chronic intermittent ethanol (CIE) vapor to induce dependence. Following CIE, mice were evaluated for physiological tolerance to ethanol and alterations in anxiety-like behaviors and memory processing. Using the ethanol responsivity battery (ERB) assay to assess physiological tolerance, we found blunted responsiveness to the intoxicating effects of ethanol in the CIE-exposed females, indicating heightened ethanol tolerance that persists beyond the acute withdrawal phase. A cohort underwent behavioral testing following CIE to characterize changes in anxiety-like behavior, exploration, and memory across abstinence. In early abstinence (<5 days post-CIE), CIE-exposed females showed increased exploratory behavior compared with Air controls. After one week of abstinence, CIE-exposed females displayed impaired object recognition memory. CIE-exposed females also showed increased anxiety-like behavior at protracted abstinence time points, exhibiting hyponeophagia in the novelty-suppressed feeding test at 2 weeks post-CIE. In addition, following cued fear conditioning, we found reduced extinction recall at 4 weeks post-CIE. Together, this work indicates that chronic alcohol exposure leads to increased alcohol tolerance and distinct, persistent alterations in memory and anxiety-like behavior in female mice.

  • Open Access

    Pro-inflammatory microglia drive escalated alcohol consumption during early abstinence

    by Paige E Anton, Baylee M Materia, Dennis Lovelock, Samuel McDonald, Scott Lyons, Angie Mordant, Laura E Herring, Joyce Besheer, Leon G Coleman

    Despite growing evidence that neuroimmune dysfunction contributes to Alcohol Use Disorder (AUD) pathology, the underlying neuroinflammatory mechanisms that may promote alcohol consumption are not as clear. We recently report that specific knockdown of interferon regulatory factor 7 (IRF7) in the anterior insula (aIC) mitigates escalation in ethanol self-administration in rats. In addition, we find pro-inflammatory activation of microglia contributes to other AUD-related behavioral impairments. Here, we sought to determine if pro-inflammatory activation of microglia from ethanol contributes to elevations in IRF7 and ethanol self-administration in rats. Male Wistar rats were trained under our ethanol self-administration paradigm (15% v/v; FR2 vs inactive lever) followed by 1-4 cycles of chronic intermittent ethanol vapor exposure (CIE). To inhibit microglia, rats were treated with minocycline (30mg/kg, i.p.) before and after each ethanol vapor session. Escalation in self-administration and biochemical markers were assessed 72 hours into abstinence. We found CIE increased ethanol self-administration, which was positively correlated with aIC IRF7 levels. Minocycline treatment blunted IRF7 expression and alleviated ethanol self-administration following CIE. LC-MS/MS proteomics of primary microglia from the aIC of rats following CIE with and without minocycline treatment indicate minocycline promotes metabolic and ribosomal re-wiring of microglia during early abstinence. These data suggest a role for microglia in driving both IRF7 levels and escalation in ethanol self-administration in early abstinence.

  • Open Access

    Microglia Promote Neurodegeneration and Hyperkatifeia during Withdrawal and Abstinence from Binge Alcohol

    by Elizabeth M. McNair, Lamar W. Dawkins, Baylee Materia, Grace Ross, Alexandra Barnett, Puja Nakkala, Liya Qin, Jian Zou, Viktoriya Nikolova, Sheryl Moy, et al.